Overview
Clinical Meaning
T2DM features insulin resistance and progressive beta cell dysfunction.
PMHNP
PMHNP
T2DM features insulin resistance and progressive beta-cell dysfunction. Insulin resistance from TNF-alpha, IL-6, free fatty acids impairs IRS phosphorylation. Beta-cell compensation fails through glucotoxicity and lipotoxicity. First-line: metformin + lifestyle. Second-line based on comorbidities: SGLT2i or GLP-1RA for ASCVD, HF, CKD. Connect Antidiabetic Medications to bedside cues you will reassess first: vitals trends, work of breathing, perfusion, mentation, and pain or ischemic equivalents when relevant. NCLEX items often reward recognizing when subtle instability outweighs reassurance, then selecting nursing actions that protect airway, circulation, and neurologic status before routine tasks.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this PMHNP pathway. You can still explore topic-filtered questions from the bank hubs below.